Understanding the role of adalimumab in the treatment of moderately to severely active ulcerative colitis

Jae Hyun Kim, Jae Hee Cheon

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)162-163
Number of pages2
JournalGut and liver
Volume10
Issue number2
DOIs
Publication statusPublished - 2016 Mar

Fingerprint

Antibodies, Monoclonal, Humanized
Remission Induction
Ulcerative Colitis
Adalimumab

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

@article{67a44b40556844fe86bfe638bb73bb9d,
title = "Understanding the role of adalimumab in the treatment of moderately to severely active ulcerative colitis",
author = "Kim, {Jae Hyun} and Cheon, {Jae Hee}",
year = "2016",
month = "3",
doi = "10.5009/gnl16024",
language = "English",
volume = "10",
pages = "162--163",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "2",

}

Understanding the role of adalimumab in the treatment of moderately to severely active ulcerative colitis. / Kim, Jae Hyun; Cheon, Jae Hee.

In: Gut and liver, Vol. 10, No. 2, 03.2016, p. 162-163.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Understanding the role of adalimumab in the treatment of moderately to severely active ulcerative colitis

AU - Kim, Jae Hyun

AU - Cheon, Jae Hee

PY - 2016/3

Y1 - 2016/3

UR - http://www.scopus.com/inward/record.url?scp=84960478328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960478328&partnerID=8YFLogxK

U2 - 10.5009/gnl16024

DO - 10.5009/gnl16024

M3 - Editorial

C2 - 26934881

AN - SCOPUS:84960478328

VL - 10

SP - 162

EP - 163

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 2

ER -